28-Feb-2025
Addus HomeCare’s Earnings Call Highlights Growth and Strategic Moves
TipRanks (Thu, 27-Feb 8:54 PM ET)
TipRanks (Wed, 26-Feb 5:20 AM ET)
KeyBanc Reaffirms Their Buy Rating on Addus Homecare (ADUS)
TipRanks (Wed, 26-Feb 5:20 AM ET)
Addus HomeCare to Participate in TD Cowen 45th Annual Health Care Conference
Business Wire (Tue, 25-Feb 11:00 AM ET)
Addus HomeCare Announces Fourth Quarter and Year End 2024 Financial Results
Business Wire (Mon, 24-Feb 4:05 PM ET)
Addus HomeCare Announces Fourth Quarter and Year-end 2024 Earnings Release and Conference Call
Business Wire (Mon, 10-Feb 11:00 AM ET)
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
Addus Homecare trades on the NASDAQ stock market under the symbol ADUS.
As of February 28, 2025, ADUS stock price declined to $95.77 with 235,556 million shares trading.
ADUS has a market cap of $1.74 billion. This is considered a Small Cap stock.
Last quarter Addus Homecare reported $297 million in Revenue and $1.38 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.02.
In the last 3 years, ADUS traded as high as $136.72 and as low as $73.66.
The top ETF exchange traded funds that ADUS belongs to (by Net Assets): IJR, VTI, IWM, VXF, SPSM.
ADUS has underperformed the market in the last year with a price return of +4.3% while the SPY ETF gained +18.8%. ADUS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -21.0% and -15.4%, respectively, while the SPY returned -0.4% and -2.5%, respectively.
ADUS support price is $94.62 and resistance is $98.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADUS shares will trade within this expected range on the day.